- Home
- CVU vs RNXT Comparison
CVU vs RNXT Comparison
Compare CVU & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVU | RNXT |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5M | 37.4M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CVU | RNXT |
|---|---|---|
| Price | $4.01 | $0.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 59.4K | ★ 173.5K |
| Earning Date | 03-01-2026 | 02-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.60 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $81,078,864.00 | $43,000.00 |
| Revenue This Year | N/A | $2,995.35 |
| Revenue Next Year | N/A | $219.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.02 | $0.70 |
| 52 Week High | $4.65 | $1.45 |
Technical Indicators
Market Signals| Indicator | CVU | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 59.25 | 47.67 |
| Support Level | $3.67 | $0.92 |
| Resistance Level | $4.22 | $1.03 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 86.96 | 28.50 |
Price Performance
Historical ComparisonAbout CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter, and others.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.